更多经皮瓣膜介入治疗:循环支持,EricE.Roselli,MD,声明,Medtronic咨询机构Edwards研发者DirectFlowMedical咨询机构,球囊扩张瓣膜成形术,快速心室起搏,瓣膜释放,未能送入-3,纳入161名患者,释放失败n=19,送入失败-9,植入成功88.2%,23mmValve(55),心脏穿孔*-3,26mm瓣膜(87),61.3%,38.7%,移位/栓塞-2,麻醉并发症-2,经股动脉REVIVEandREVIVALII操作结果,SuccessfulDeploymentn=142,23mm瓣膜(55),成功释放n=142,SlidecourtesyofSusheelKodali,REVIVALII经心尖技术的成功性,87.5%移位/栓塞12.5%送入失败0平均释放时间11.7min平均操作时间87.1min,THV学习曲线成功植入百分比,%,SlidecourtesyofT.Lefvre,精确释放至关重要,REVIVEvalvemigratedintoLVduringCPR*Onepatienttreatedwithleft
